PKR Regulates B56α-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells

被引:43
作者
Ruvolo, Vivian R. [1 ]
Kurinna, Svitlana M. [2 ]
Karanjeet, Kul B. [1 ]
Schuster, Todd F. [1 ]
Martelli, Alberto M. [3 ]
McCubrey, James A. [4 ]
Ruvolo, Peter P. [1 ,2 ]
机构
[1] Univ Minnesota, Hormel Inst, Sect Signal Transduct & Apoptosis, Austin, MN 55912 USA
[2] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Div Cell Signaling, Houston, TX 77030 USA
[3] Univ Bologna, Dept Human Anat Sci, I-40126 Bologna, Italy
[4] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M800951200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatase 2A (PP2A) is a heterotrimer comprising catalytic, scaffold, and regulatory (B) subunits. There are at least 21 B subunit family members. Thus PP2A is actually a family of enzymes defined by which B subunit is used. The B56 family member B56 alpha is a phosphoprotein that regulates dephosphorylation of BCL2. The stress kinase PKR has been shown to phosphorylate B56 alpha at serine 28 in vitro, but it has been unclear how PKR might regulate the BCL2 phosphatase. In the present study, PKR regulation of B56 alpha in REH cells was examined, because these cells exhibit robust BCL2 phosphatase activity. PKR was found to be basally active in REH cells as would be predicted if the kinase supports B56 alpha-mediated dephosphorylation of BCL2. Suppression of PKR promoted BCL2 phosphorylation with concomitant loss of B56 alpha phosphorylation at serine 28 and inhibition of mitochondrial PP2A activity. PKR supports stress signaling in REH cells, as suppression of PKR promoted chemoresistance to etoposide. Suppression of PKR promoted B56 alpha proteolysis, which could be blocked by a proteasome inhibitor. However, the mechanism by which PKR supports B56 alpha protein does not involve PKR-mediated phosphorylation of the B subunit at serine 28 but may involve eIF2 alpha activation of AKT. Phosphorylation of serine 28 by PKR promotes mitochondrial localization of B56 alpha, because wild-type but not mutant S28A B56 alpha promoted mitochondrial PP2A activity. Cells expressing wildtype B56 alpha but not S28A B56 alpha were sensitized to etoposide. These results suggest that PKR regulates B56 alpha-mediated PP2A signaling in REH cells.
引用
收藏
页码:35474 / 35485
页数:12
相关论文
共 43 条
[1]   The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia [J].
Abraham, N ;
Jaramillo, ML ;
Duncan, PI ;
Méthot, N ;
Icely, PL ;
Stojdl, DF ;
Barber, GN ;
Bell, JC .
EXPERIMENTAL CELL RESEARCH, 1998, 244 (02) :394-404
[2]  
Basu S, 1997, CANCER RES, V57, P943
[3]  
Beretta L, 1996, ONCOGENE, V12, P1593
[4]   A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress [J].
Boyce, M ;
Bryant, KF ;
Jousse, C ;
Long, K ;
Harding, HP ;
Scheuner, D ;
Kaufman, RJ ;
Ma, DW ;
Coen, DM ;
Ron, D ;
Yuan, JY .
SCIENCE, 2005, 307 (5711) :935-939
[5]   REGULATION OF PROTEIN SERINE-THREONINE PHOSPHATASE TYPE-2A BY TYROSINE PHOSPHORYLATION [J].
CHEN, J ;
MARTIN, BL ;
BRAUTIGAN, DL .
SCIENCE, 1992, 257 (5074) :1261-1264
[6]   Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40 [J].
Chen, Yu ;
Xu, Yanhui ;
Bao, Qing ;
Xing, Yongna ;
Li, Zhu ;
Lin, Zheng ;
Stock, Jeffry B. ;
Jeffrey, Philip D. ;
Shi, Yigong .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (06) :527-534
[7]   Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme [J].
Cho, Uhn Soo ;
Xu, Wenqing .
NATURE, 2007, 445 (7123) :53-57
[8]   Activation of PKR: an open and shut case? [J].
Cole, James L. .
TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (02) :57-62
[9]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789
[10]   TUMOR PROMOTION BY INHIBITORS OF PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A - THE OKADAIC ACID CLASS OF COMPOUNDS [J].
FUJIKI, H ;
SUGANUMA, M .
ADVANCES IN CANCER RESEARCH, VOL 61, 1993, 61 :143-194